Company / Cash & Equivalents
Waystar Holding Corp Cash & Equivalents History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$61.4M
FY2025
5-year range
$35.6M / $182.1M
FY2022-FY2025
Trend
-66.3%
vs FY2024
Sector context
#128 of 148
Health Care
What the data says
Waystar Holding Corp's cash & equivalents of $61M is lower than 86% of companies in the Health Care sector (FY2025). Improved from $36M to $61M over the past 2 years.
Based on SEC 10-K filings.
$61M in FY2025 with a 3-year CAGR of -1.7%.
Improved from $36M to $61M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 148This company $61.4M Sector average $1.2B
▼
-94.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -1.7%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 66.3% year-over-year.
- Ranks #128 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.4M | -66.3% |
| FY2024 | $182.1M | +411.9% |
| FY2023 | $35.6M | -44.9% |
| FY2022 | $64.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026